Literature DB >> 13678867

Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Kenneth L Davis1, Vahram Haroutunian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678867     DOI: 10.1016/S0140-6736(03)14297-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Mouse intermittent hypoxia mimicking apnoea of prematurity: effects on myelinogenesis and axonal maturation.

Authors:  Jun Cai; Chi Minh Tuong; Yiping Zhang; Christopher B Shields; Gang Guo; Hui Fu; David Gozal
Journal:  J Pathol       Date:  2011-10-18       Impact factor: 7.996

2.  Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia.

Authors:  Shruti N Mitkus; Thomas M Hyde; Radhakrishna Vakkalanka; Bhaskar Kolachana; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Journal:  Schizophr Res       Date:  2007-10-26       Impact factor: 4.939

3.  Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth.

Authors:  Stéphane Budel; Thihan Padukkavidana; Betty P Liu; Zeny Feng; Fenghua Hu; Sam Johnson; Juha Lauren; James H Park; Aaron W McGee; Ji Liao; Althea Stillman; Ji-Eun Kim; Bao-Zhu Yang; Stefano Sodi; Joel Gelernter; Hongyu Zhao; Fuki Hisama; Amy F T Arnsten; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

4.  Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorder.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Dorota Maciag; Monica Sathyanesan; Abiye H Iyo; Mohadetheh Moulana; Patrick B Kyle; William L Woolverton; Jose Javier Miguel-Hidalgo; Craig A Stockmeier; Samuel S Newton
Journal:  J Psychiatr Res       Date:  2015-04-20       Impact factor: 4.791

5.  Specific glial functions contribute to schizophrenia susceptibility.

Authors:  Andrea Goudriaan; Christiaan de Leeuw; Stephan Ripke; Christina M Hultman; Pamela Sklar; Patrick F Sullivan; August B Smit; Danielle Posthuma; Mark H G Verheijen
Journal:  Schizophr Bull       Date:  2013-08-16       Impact factor: 9.306

6.  Neuron-specific Enolase and myelin basic protein in cerebrospinal fluid of patients with first episode schizophrenia.

Authors:  Shuying Li; Hanrong Wu; Huirong Guo; Zheng Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 7.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

Review 8.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models.

Authors:  Hanna Jaaro-Peled; Yavuz Ayhan; Mikhail V Pletnikov; Akira Sawa
Journal:  Schizophr Bull       Date:  2009-11-10       Impact factor: 9.306

9.  Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.

Authors:  M R Bryant; C B Marta; F S Kim; R Bansal
Journal:  Glia       Date:  2009-07       Impact factor: 7.452

Review 10.  Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

Authors:  Andreas Konrad; Georg Winterer
Journal:  Schizophr Bull       Date:  2007-05-07       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.